Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02042638
Other study ID # 27122013
Secondary ID
Status Completed
Phase N/A
First received December 28, 2013
Last updated January 22, 2014
Start date January 2011
Est. completion date August 2013

Study information

Verified date December 2013
Source Gulhane School of Medicine
Contact n/a
Is FDA regulated No
Health authority Turkey: Ethics Committee
Study type Observational [Patient Registry]

Clinical Trial Summary

Effects of hCG replacement therapy on metabolic syndrome parameters in hypogonadotrophic hypogonadism.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date August 2013
Est. primary completion date August 2013
Accepts healthy volunteers No
Gender Male
Age group 16 Years to 45 Years
Eligibility Inclusion Criteria: Serum testosterone concentration < 300ng/dL Absence of a pituitary or hypothalamic mass lesions, Presence of gonadotropin response to GnRH, -

Exclusion Criteria: Previous androgen treatment, diabetes mellitus, arterial hypertension other hormone deficiencies

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Drug:
hCG 1500 IU three times a week

Pregnyl (hCG) ampule 1500 IU/three times a week


Locations

Country Name City State
Turkey Gulhane School of Medicine Dep. of Endocrinology and Metabolism Ankara

Sponsors (1)

Lead Sponsor Collaborator
Gulhane School of Medicine

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary HDL after hCG treatment 2011-2013 2011-2013 Yes
Primary LDL levels after hCG treatment 2011-2013 Yes
Primary total cholesterole levels after hCG treatment 2011-2013 Yes
Secondary Body fat ratio after hCG treatment 2011-2013 Yes
Secondary hsCRP levels after hCG treatment 2011-2013 Yes
See also
  Status Clinical Trial Phase
Completed NCT02728440 - Effects of Gonadotropin Replacement Therapy on Metabolic Parameters in Patients With Hypogonadism N/A
Terminated NCT01165619 - Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders N/A
Completed NCT01914172 - Health Needs of Patients With Kallmann Syndrome N/A
Active, not recruiting NCT02310074 - Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism Phase 4
Completed NCT01758094 - Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism N/A
Completed NCT01601327 - Effects of Medications in Patients With Hypogonadism Phase 4
Completed NCT00493961 - Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism Phase 1
Recruiting NCT05569577 - An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients N/A